Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours

Autor: Sjoukje F Oosting, Astrid A M van der Veldt, Rudolf S N Fehrmann, Corine H GeurtsvanKessel, Rob S van Binnendijk, Anne-Marie C Dingemans, Egbert F Smit, T Jeroen N Hiltermann, Gerco den Hartog, Mathilda Jalving, Tatjana T Westphal, Arkajyoti Bhattacharya, Faye de Wilt, Annemarie Boerma, Lisanne van Zijl, Guus F Rimmelzwaan, Pia Kvistborg, Cecile A C M van Els, Nynke Y Rots, Debbie van Baarle, John B A G Haanen, Elisabeth G E de Vries
Přispěvatelé: AII - Cancer immunology, CCA - Cancer Treatment and quality of life, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Translational Immunology Groningen (TRIGR), Targeted Gynaecologic Oncology (TARGON), Medical Oncology, Radiology & Nuclear Medicine, Virology, Pulmonary Medicine
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Zdroj: The Lancet Oncology, 23(7), 833-835. Lancet Publishing Group
Lancet Oncology, 23(7), 833-835. ELSEVIER SCIENCE INC
Oosting, S F, van der Veldt, A A M, Fehrmann, R S N, GeurtsvanKessel, C H, van Binnendijk, R S, Dingemans, A-M C, Smit, E F, Hiltermann, T J N, den Hartog, G, Jalving, M, Westphal, T T, Bhattacharya, A, de Wilt, F, Boerma, A, van Zijl, L, Rimmelzwaan, G F, Kvistborg, P, van Els, C A C M, Rots, N Y, van Baarle, D, Haanen, J B A G & de Vries, E G E 2022, ' Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours ', The Lancet Oncology, vol. 23, no. 7, pp. 833-835 . https://doi.org/10.1016/S1470-2045(22)00203-0
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(22)00203-0
Databáze: OpenAIRE